MNC pharma: Time to relook at them? 8 pharma stocks, 4 with an upside potential of between 16 and 47%
In the past four years, several MNC pharma companies announced the sale of a part of their businesses in India. Some of this was part of global readjustments being made at the parent companies’ level. The question for us: Will these restructured MNC pharma …